Hemas Pharmaceuticals

What Hemas Pharmaceuticals does

Hemas Pharmaceuticals (Pvt) Ltd. is the market-leading pharmaceutical importer and distributor in Sri Lanka, operating as a wholly-owned subsidiary of Hemas Holdings PLC, a diversified conglomerate listed on the Colombo Stock Exchange. The company distributes pharmaceutical, surgical, diagnostic, consumer health, and animal health products across five revenue streams: pharmaceutical distribution, surgical and diagnostics distribution, consumer health distribution, animal health distribution, and marketing/channel solutions provided to global principals. It represents 4 of the top 5 pharmaceutical companies operating in Sri Lanka and over 50 multinational brands, including Abbott, Roche, Terumo, and Nihon Kohden, with field sales and distribution coverage described as the most extensive and comprehensive in the country. Hemas employs more than 1,400 staff across its operations.

The company's technology stack centers on Big Data-powered digital integrated infrastructure supporting end-to-end digital connectivity across the supply chain, supplemented by online learning platforms for the field force. Distribution channels include direct enterprise field sales reaching healthcare institutions across Sri Lanka, the proprietary Healthnet E-Pharmacy platform for 24/7 direct consumer access, and regional operations through Hemas Mandalar Pharmaceuticals Limited in Myanmar (established 2017 with 15+ distribution points) plus Maldives. Pricing is negotiated per-customer under multi-year contracts in a B2B distribution model. The company maintains ISO 9001:2015 certification, Good Distribution Practices certification, and COVID-19 Safety Management System certification, supporting in-house regulatory compliance and medico-marketing capabilities.

Hemas serves healthcare institutions and providers, pharmaceutical manufacturers, hospitals and surgical centers, and individual consumers in Sri Lanka, with regional expansion into Myanmar and Maldives. The company holds certifications including Great Place to Work and maintains partnerships with healthcare professionals through Pharmacists Skills Development Programs. It is led by Managing Director Jude Fernando and Director Sales Chinthaka Perera, and operates as part of the Hemas Group, ranked among the top 15 listed entities on the Colombo Stock Exchange.

Name

Hemas Pharmaceuticals

Legal name

Hemas Pharmaceuticals (Pvt) Ltd.

Website

https://hemashealthcare.com

Company type

Private

Founded year

1950

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Hemas Pharmaceuticals is Sri Lanka's market-leading importer and distributor of pharmaceutical, surgical, diagnostic, consumer health, and animal health products, representing 4 of the top 5 pharma companies and 50+ multinational brands across 1,400+ staff with regional operations in Myanmar and Maldives.

Ownership category

akta.pro rank

Headquarters

HQ city

Colombo

HQ country

Sri Lanka

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Pharmaceutical Product Distribution: Importation and distribution of pharmaceutical products as the market leader in Sri Lanka
2. Surgical and Diagnostics Distribution: Distribution of medical devices, diagnostics solutions including hypodermic syringes, infusion solutions, cardiac devices, wound care products, and diagnostic equipment
3. Consumer Health Distribution: Distribution of consumer health products
4. Animal Health Distribution: Distribution of animal health products
5. Marketing and Channel Solutions: World class marketing and channel solutions provided to global portfolio of brands and partners

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Hemas Pharmaceuticals is an importer, marketer, and distributor of pharmaceutical, surgical, diagnostic, consumer health, and animal health products in Sri Lanka and select regional markets. It serves as a key intermediary between global manufacturers and local healthcare providers, offering branded prescription, OTC, medical device, and diagnostic solutions alongside the Healthnet E-Pharmacy platform for consumer access.

Product overview

Hemas Pharmaceuticals operates as a pharmaceutical and medical devices distributor with a multi-brand portfolio strategy. The core offerings include the proprietary Healthnet E-Pharmacy platform providing 24/7 online access to pharmaceuticals, supplemented by distributed international brands across diagnostics (Abbott Diagnostics Division, Roche Diabetes Care), blood management (Terumo BCT), medical equipment (Nihon Kohden), and hospital supplies. The Hemas Surgicals & Diagnostics division handles medical devices and diagnostic solutions including cardiovascular products, diagnostic analyzers, defibrillators, and surgical supplies. The company serves healthcare institutions across Sri Lanka through an extensive distribution network, with operations extending to Myanmar and Maldives.

Differentiator

Problem solved

Functional benefit

Brands

• Healthnet: E-Pharmacy platform launched by Hemas Pharmaceuticals allowing customers 24/7 access to the full range of products

Products and services

• Pharmaceutical Distribution

Quantifiable outcome

• Market leader in Sri Lanka for pharmaceuticals
• +1 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• Medihelp HospitalsminorStrategic or Co-development Partner · 1 October 2025Hemas Pharmaceuticals partnered with Medihelp Hospitals to conduct diabetes screening and awareness programmes in Sri Lanka, starting October 2025. The events included free health screenings and education aimed at supporting patients with diabetes and promoting early detection.
• Hemas Mandalar Pharmaceuticals LimitedcoreChannel Partner/ Reseller/ DistributorRegional subsidiary in Myanmar, operational since 2017, with more than 15 agencies and distribution points across the country.
• 4 out of Top 5 Pharmaceutical Companies in Sri LankacoreChannel Partner/ Reseller/ DistributorRepresents 4 out of the top 5 pharmaceutical companies operating in Sri Lanka as the exclusive or primary distribution partner.
• 50+ Multinational Companies and Global BrandscoreChannel Partner/ Reseller/ DistributorRepresents over 50 multinational companies and global brands in Sri Lanka and other parts of the region through distribution, marketing, and channel solutions.
• Healthcare Professionals and Medical CommunitycoreOthersStrong industry standing among the business and medical community, providing continuing education through Pharmacists Skills Development Programs.
• Mahela Jayawardena and Kumar SangakkaraminorGTM or Marketing PartnerCricket icons partnered with Hemas to donate a PCR machine to Lady Ridgeway Hospital for children, supporting the nation's COVID-19 fight.
• Hemas Group of CompaniescoreOthersHemas Pharmaceuticals is a member of the Hemas Group, one of Sri Lanka's most successful conglomerates, ranked top 10 most respected business entities by LMD magazine.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Others

• DHL Supply Chain (Life Sciences & Healthcare): Global contract logistics provider with dedicated life sciences and healthcare distribution operations across Asia. Relevant as an adjacent/thematically related logistics and distribution service provider, and a potential competitor for pharma third-party logistics contracts.
• World Courier (Cencora subsidiary): Specialty logistics and distribution services company for pharma and biotech, with strong Asia presence. Comparable as a participant in the pharma distribution value chain, particularly for specialty and high-value products.

Regional players

• Cipla: India-headquartered pharmaceutical manufacturer with significant South Asia distribution presence, including Sri Lanka. Operates as both a manufacturer and distributor of pharmaceuticals in the region, with overlapping target markets and principals to Hemas.

Direct peers

• DKSH Holding: Switzerland-listed market expansion services company with a Healthcare business unit distributing pharmaceuticals, medical devices, and consumer health products across Asia. Highly comparable to Hemas in providing distribution, marketing, and channel solutions to global healthcare brands in Asian markets.
• Zuellig Pharma: One of the largest healthcare distribution services companies in Asia, providing pharma and medical device distribution, sales, and marketing services across multiple Asian markets. Directly comparable to Hemas as a regional pharma distribution specialist with a similar business model of representing global principals in local/regional markets.

Broad incumbents

• Sinopharm Group: China's largest pharmaceutical and healthcare distributor, operating a similar pharma import/distribution model at significantly larger scale. Relevant as a broad incumbent showing the upper-bound architecture of pharma distribution in Asia.
• Shanghai Pharmaceuticals Holding: Major Chinese pharmaceutical manufacturer and distributor with both manufacturing and nationwide distribution operations. Comparable as a vertically integrated pharma distribution incumbent in Asia.
• McKesson Corporation: One of the largest global pharmaceutical distributors and wholesalers. Relevant as a broad incumbent illustrating the strategic model Hemas operates within — pharma distribution at scale to hospitals, pharmacies, and institutions.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical distribution and solutions company serving manufacturers, pharmacies, and healthcare providers worldwide. Comparable as a broad incumbent in the wholesale pharma distribution space.
• Cardinal Health: Large US-headquartered pharmaceutical and medical product distributor with global reach. Comparable as a broad incumbent providing pharma and medical product wholesale and distribution services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/hemaspharma
• LinkedInlinkedin.com/company/hemaspharmaceuticalspvtltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hemas Pharmaceuticals